<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lewis CJT</submitter><funding>American Cancer Society</funding><funding>National Institute of Diabetes and Digestive and Kidney Diseases</funding><funding>NIDDK NIH HHS</funding><funding>Pfizer</funding><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><funding>National Institute of General Medical Sciences</funding><funding>NIGMS NIH HHS</funding><funding>National Science Foundation</funding><pagination>445-459.e5</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11780321</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>85(2)</volume><pubmed_abstract>mRNA therapeutics offer a potentially universal strategy for the efficient development and delivery of therapeutic proteins. Current mRNA vaccines include chemically modified nucleotides to reduce cellular immunogenicity. Here, we develop an efficient, high-throughput method to measure human translation initiation on therapeutically modified as well as endogenous RNAs. Using systems-level biochemistry, we quantify ribosome recruitment to tens of thousands of human 5' untranslated regions (UTRs) including alternative isoforms and identify sequences that mediate 200-fold effects. We observe widespread effects of coding sequences on translation initiation and identify small regulatory elements of 3-6 nucleotides that are sufficient to potently affect translational output. Incorporation of N1-</pubmed_abstract><journal>Molecular cell</journal><pubmed_title>Quantitative profiling of human translation initiation reveals elements that potently regulate endogenous and therapeutically modified mRNAs.</pubmed_title><pmcid>PMC11780321</pmcid><funding_grant_id>F31 DK129022</funding_grant_id><funding_grant_id>DGE2139841</funding_grant_id><funding_grant_id>R01 GM132358</funding_grant_id><funding_grant_id>PF-23-1144579-01-RMC</funding_grant_id><funding_grant_id>ITEN2021.RNA01</funding_grant_id><funding_grant_id>R01 GM101316</funding_grant_id><funding_grant_id>R01GM132358</funding_grant_id><funding_grant_id>2330451</funding_grant_id><funding_grant_id>F31CA254339</funding_grant_id><funding_grant_id>F31 CA254339</funding_grant_id><funding_grant_id>F31DK129022</funding_grant_id><funding_grant_id>R35 GM152167</funding_grant_id><funding_grant_id>R35GM152167</funding_grant_id><pubmed_authors>Thoreen CC</pubmed_authors><pubmed_authors>Abdallah K</pubmed_authors><pubmed_authors>Gilbert WV</pubmed_authors><pubmed_authors>Jin D</pubmed_authors><pubmed_authors>Xie LH</pubmed_authors><pubmed_authors>Draycott AS</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Lewis CJT</pubmed_authors><pubmed_authors>Bhandarkar SM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Quantitative profiling of human translation initiation reveals elements that potently regulate endogenous and therapeutically modified mRNAs.</name><description>mRNA therapeutics offer a potentially universal strategy for the efficient development and delivery of therapeutic proteins. Current mRNA vaccines include chemically modified nucleotides to reduce cellular immunogenicity. Here, we develop an efficient, high-throughput method to measure human translation initiation on therapeutically modified as well as endogenous RNAs. Using systems-level biochemistry, we quantify ribosome recruitment to tens of thousands of human 5' untranslated regions (UTRs) including alternative isoforms and identify sequences that mediate 200-fold effects. We observe widespread effects of coding sequences on translation initiation and identify small regulatory elements of 3-6 nucleotides that are sufficient to potently affect translational output. Incorporation of N1-</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2026-06-06T15:23:43.474Z</modification><creation>2026-06-01T03:11:06.846Z</creation></dates><accession>S-EPMC11780321</accession><cross_references><pubmed>39706187</pubmed><doi>10.1016/j.molcel.2024.11.030</doi></cross_references></HashMap>